30 results about "Sparfloxacin" patented technology

Provided is a ureaplasma urealyticum/mycoplasma hominis combined rapid culture and drug sensitivity detection kit. The kit can complete detection in 8-24 h, and meanwhile, drug-resistant detection of various antibiotics can be performed. The combined rapid culture kit is mainly composed of pork stomach digestive juice or lung digestive juice, a beef extracting solution or a beef heart extracting solution, cattle serum or horse serum or other animal serum, sodium chloride, peptone, yeast powder, urea, L-arginine, phenol red indicator or cresol red indicator, and penicillin or other antibiotics. The drug detection kit can detect doxycycline hyclate, roxithromycin, acetylspiramycin, gatifloxacin, clarithromycin, azithromycin, clindamycin, erythromycin, kitasamycin, ofloxacin, levofloxacin hydrochloride, sparfloxacin, ciprofloxacin, doxycycline, erythromycin cydocarbonate and various other antibiotics. By means of the detection kit, not only is the mycoplasma detection time shortened, but also drug-resistant detection can be performed at the same time so that clinical medication can be guided. The detection kit has the beneficial effects of being high in sensitivity, high in specificity, high in detection rate, easy and convenient to operate and the like.

The present invention discloses a neoquinonones antibacterial agent, its synthesis method and application, in particular, discloses a sparflaxacin salt, its synthesis and application. It utilizes sparflaxacin and polyhydroxyl monocarboxylic acid, are used and reacted to obtain the invented sparflaxacin salt. It is made into crystal, easy to dissolve in water, good in aqueous solution stability, and can be made into infusion preparation and injection for antibacterial therapy, and overcomes the defect of existent sparflaxacin salt, for example sparflaxacin lactate whose aqueous solution is not stable.